All News

diet.better.jpg

NY Times on Arthritis Prevention

d Jack Cush, MD

A reader question ("Ask Well") to the New York times wonders "is arthritis avoidable"?



A recent survey suggests that up to 60% of adults have been told by an HCP they had some form of arthritis.

Read Article
RheumNow Podcast square

Want to Go Far, Go Together (4.21.2023)

d Jack Cush, MD

This week on the podcast Dr. Jack Cush reviews the news, regulatory announcements and novel journal reports including a profile on pseudogout, the safety of immune checkpoint inhibitors in RA patients and the diagnostic importance of neutrophils.

Read Article
TNR: Private Practice & Academia In this session, our panelists addressed the big questions of: "How do I choose between private practice and academia?" and "How do I advance in my career?". https://t.co/yMJ5mCtSXX @KDAO2011 https://t.co/eeFYkLYsAh

Links:

Dr. John Cush RheumNow ( View Tweet)
Immune Checkpoint Inhibitor Safety with Pre-existing Rheumatoid Arthritis Lancet Rheumatology has published a retrospective analysis showing patients receiving ICI for cancer have the same outcomes even when they have pre-existing RA. https://t.co/Tjj827nPTT https://t.co/nBBgI9wpjR

Links:

Dr. John Cush RheumNow ( View Tweet)
Study of 9558 pts found significant associations betw migraine and CTS Median nerve decompression (OR, 1.3) & multiple nerve decompressions (OR, 1.7). Also assoc w/ migraine: psych dz, RA, CVS, hypothyroid, HTN, COPD https://t.co/cIdkACHGwB https://t.co/VO3VqujzSQ

Links:

Dr. John Cush RheumNow ( View Tweet)
Real world interchangeabilty study compared rituximab to biosimilar ( CT-P10) in 128 Rheum pts (CT-P10= 64; RTX= 64), with 41% of pts switched from RTX to CT-P10. Both Rx had Comparable Gr 2 infuxion Rxs, infection #s & hypogammaglobulinemia (p > 0.05) https://t.co/RNxt7Xn7MJ https://t.co/u3yJNQQIMC

Links:

Dr. John Cush RheumNow ( View Tweet)
arthritis.RA_.Xray_.hands_.jpg (keep)

Immune Checkpoint Inhibitor Safety with Pre-existing Rheumatoid Arthritis

d Jack Cush, MD

Lancet Rheumatology has published a retrospective analysis showing patients receiving immune checkpoint inhibitors (ICI) for cancer have the same outcomes (mortality and severe immune-related adverse events (irAEs)) even when they have pre-existing rheumatoid arthritis (RA).

Read Article
Retrospective study on prescribing by male vs female RHEUMs, found that women (in private practice, >10 yrs) were less likely to be High steroid prescribers. RA Pts more likely to Rx steroids = male sex, >prior biologics, opioid use, w/ comorbidities & freq infx https://t.co/eO3yJRCfOR
Dr. John Cush RheumNow ( View Tweet)
Clinical Profile of RA-associated Interstitial Lung Disease A prospective, cross-sectional analysis of patients with rheumatoid arthritis (RA) shows those with interstitial lung disease (ILD) tend to be older, obese and have a smoking history. https://t.co/FazEGcHh5H https://t.co/oh6oIpj21k

Links:

Dr. John Cush RheumNow ( View Tweet)
RA Patients on Biologics and tsDMARDs are still High Risk A new Swedish ARTIS registry study of key safety outcomes in RA patients receiving either targeted synthetic or b/ts DMARDs, including JAKi, has been updated and affirms previously held risks. https://t.co/mqfP4deGJv https://t.co/m43GSRlrct

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumNow Podcast square

The Match Game (4.14.2023)

d Jack Cush, MD

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com, including Rheumatology success in the NRMP MATCH, Cocaine vasculitis and worrisome safety risks with Biologics and tsDMARDs.

Read Article
Clinical Profile of RA-associated Interstitial Lung Disease A prospective, cross-sectional analysis of patients with rheumatoid arthritis (RA) shows those with interstitial lung disease (ILD) tend to be older, obese and have a smoking history. https://t.co/Khe9jV1jGa https://t.co/WejiaxolQP

Links:

Dr. John Cush RheumNow ( View Tweet)
Join us April 18 for: Private Practice & Academia In this session, our panelists will address the big questions of: "How do I choose between private practice and academia?" and "How do I advance in my career?". https://t.co/BrWG57mRRG https://t.co/A0pzEvJ3cu

Links:

Dr. John Cush RheumNow ( View Tweet)
pill,pain,med,hand

Pain and Opioid Updates

d Jack Cush, MD

Today, the CDC and FDA provided new updates on the scope of pain in the USA and guidance on the use of opioids.



MMWR April 14, 2023

Read Article
COVID had a significant effect on mental health of inflammatory rheumatic Dz (IRDs) pts. UK NHS survey of 639 IRD (70% RA, 16% PsA) saw 40% w/ mod/severe pandemic impact on physical & mental health; 29% w/ depression, 22% anxiety; affecting Women>males https://t.co/odUCjScMBZ https://t.co/Eb1E2In5z1

Links:

Dr. John Cush RheumNow ( View Tweet)
Pooled analysis of 5 RCTs of tocilizumab vs DMARDs in 4474 female #RA pts- 63% postmenopausal, 23% premenopausal, 9% perimenopausal. Perimenopausal F had less remission (HR 0.78); but exogenous Sex hormone use had higher remission (HR 1.20) https://t.co/zmvpzFlBRQ https://t.co/lUbGKr4akR

Links:

Dr. John Cush RheumNow ( View Tweet)
Predictors of RA-ILD include smoking, Dz activity, steroid use and obesity. @jeffsparks @UTSW_Rheum https://t.co/VRQc9igHWW
Dr. John Cush RheumNow ( View Tweet)
Methotrexate-induced pneumonitis (0.3% risk) is different than RA-ILD. MTX does not increase odds of RA-ILD. @jeffsparks @UTSW_Rheum https://t.co/JV1CcB0sLP
Dr. John Cush RheumNow ( View Tweet)
Disease activity increases the risk of future RA-ILD. For every one point increase in DAS28, theres a 35% increase risk of RA-ILD @jeffsparks @UTSW_Rheum https://t.co/P3dNDVanuL
Dr. John Cush RheumNow ( View Tweet)
Survival in RA-ILD is reduced (data from two different eras) @jeffsparks @UTSW_Rheum https://t.co/7eGgGnEgwW
Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright {{ 'now'|date('Y') }} All Rights Reserved.